Development of colloidal rare-earth arsenites as arsenic trioxide nanoparticle prodrugs (ATONP) for chemotherapy on a patient-derived xenograft model of colorectal cancer

New J. Chem., 2019, Advance Article DOI: 10.1039/C9NJ02990G, PaperXin Fu, Hua-qing Zhang, Jun Zhao, Lu-lu Yu, Qing-rong Liang, Yu Zhang, Xiu-Guang Yi, Yong-xiu Li, Ji-long Hu, Yuan-qiao He, Qun Tang Rare earth arsenite colloids, acting as arsenic trioxide nanoparticle prodrugs, effectively arrested cancer growth in a patient-derived colorectal xenograft model. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry

Source: RSC - New J. Chem. latest articles - October 31, 2019 Category: Chemistry Authors: Xin Fu Source Type: research